vs
Side-by-side financial comparison of ENNIS, INC. (EBF) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
ENNIS, INC. is the larger business by last-quarter revenue ($100.2M vs $83.1M, roughly 1.2× PROCEPT BioRobotics Corp). ENNIS, INC. runs the higher net margin — 10.8% vs -38.1%, a 48.9% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 0.4%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 1.4%).
ENNIS, INC. (ticker EBF) is a leading North American provider of printed business products and related services. Its offerings include custom business forms, pressure-sensitive labels, marketing collateral, promotional items, and branded packaging, serving clients across retail, healthcare, financial services, and small business segments.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
EBF vs PRCT — Head-to-Head
Income Statement — Q3 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $100.2M | $83.1M |
| Net Profit | $10.8M | $-31.6M |
| Gross Margin | 31.9% | 64.9% |
| Operating Margin | 15.0% | -4.1% |
| Net Margin | 10.8% | -38.1% |
| Revenue YoY | 0.4% | 20.2% |
| Net Profit YoY | 6.1% | -27.9% |
| EPS (diluted) | $0.42 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $83.1M | ||
| Q4 25 | $100.2M | $76.4M | ||
| Q3 25 | $98.7M | $83.3M | ||
| Q2 25 | $97.2M | $79.2M | ||
| Q1 25 | $92.7M | $69.2M | ||
| Q4 24 | $99.8M | $68.2M | ||
| Q3 24 | $99.0M | $58.4M | ||
| Q2 24 | $103.1M | $53.4M |
| Q1 26 | — | $-31.6M | ||
| Q4 25 | $10.8M | $-29.8M | ||
| Q3 25 | $13.2M | $-21.4M | ||
| Q2 25 | $9.8M | $-19.6M | ||
| Q1 25 | $9.0M | $-24.7M | ||
| Q4 24 | $10.2M | $-18.9M | ||
| Q3 24 | $10.3M | $-21.0M | ||
| Q2 24 | $10.7M | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | 31.9% | 60.6% | ||
| Q3 25 | 30.5% | 64.8% | ||
| Q2 25 | 31.1% | 65.4% | ||
| Q1 25 | 29.5% | 63.9% | ||
| Q4 24 | 29.3% | 64.0% | ||
| Q3 24 | 30.1% | 63.2% | ||
| Q2 24 | 30.0% | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | 15.0% | -40.6% | ||
| Q3 25 | 12.5% | -27.8% | ||
| Q2 25 | 13.7% | -28.0% | ||
| Q1 25 | 13.0% | -39.7% | ||
| Q4 24 | 13.1% | -28.9% | ||
| Q3 24 | 13.3% | -38.4% | ||
| Q2 24 | 13.3% | -50.3% |
| Q1 26 | — | -38.1% | ||
| Q4 25 | 10.8% | -39.1% | ||
| Q3 25 | 13.3% | -25.7% | ||
| Q2 25 | 10.1% | -24.7% | ||
| Q1 25 | 9.7% | -35.8% | ||
| Q4 24 | 10.2% | -27.6% | ||
| Q3 24 | 10.4% | -35.9% | ||
| Q2 24 | 10.4% | -48.0% |
| Q1 26 | — | $-0.56 | ||
| Q4 25 | $0.42 | $-0.54 | ||
| Q3 25 | $0.51 | $-0.38 | ||
| Q2 25 | $0.38 | $-0.35 | ||
| Q1 25 | $0.34 | $-0.45 | ||
| Q4 24 | $0.39 | $-0.34 | ||
| Q3 24 | $0.40 | $-0.40 | ||
| Q2 24 | $0.41 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.3M | $245.6M |
| Total DebtLower is stronger | — | $51.7M |
| Stockholders' EquityBook value | $304.8M | $347.7M |
| Total Assets | $354.3M | $487.1M |
| Debt / EquityLower = less leverage | — | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.6M | ||
| Q4 25 | $31.3M | $286.5M | ||
| Q3 25 | $31.9M | $294.3M | ||
| Q2 25 | $32.6M | $302.7M | ||
| Q1 25 | $72.5M | $316.2M | ||
| Q4 24 | $68.6M | $333.7M | ||
| Q3 24 | $122.6M | $196.8M | ||
| Q2 24 | $123.7M | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | — | $51.6M | ||
| Q3 25 | — | $51.6M | ||
| Q2 25 | — | $51.5M | ||
| Q1 25 | — | $51.5M | ||
| Q4 24 | — | $51.5M | ||
| Q3 24 | — | $51.4M | ||
| Q2 24 | — | $51.4M |
| Q1 26 | — | $347.7M | ||
| Q4 25 | $304.8M | $365.9M | ||
| Q3 25 | $305.4M | $380.3M | ||
| Q2 25 | $301.2M | $385.8M | ||
| Q1 25 | $302.0M | $389.2M | ||
| Q4 24 | $297.7M | $402.2M | ||
| Q3 24 | $358.4M | $241.2M | ||
| Q2 24 | $354.4M | $251.8M |
| Q1 26 | — | $487.1M | ||
| Q4 25 | $354.3M | $508.1M | ||
| Q3 25 | $361.8M | $511.5M | ||
| Q2 25 | $361.7M | $513.1M | ||
| Q1 25 | $348.9M | $519.4M | ||
| Q4 24 | $346.1M | $534.0M | ||
| Q3 24 | $406.8M | $374.1M | ||
| Q2 24 | $406.2M | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.4M | — |
| Free Cash FlowOCF − Capex | $15.7M | — |
| FCF MarginFCF / Revenue | 15.7% | — |
| Capex IntensityCapex / Revenue | 0.7% | — |
| Cash ConversionOCF / Net Profit | 1.52× | — |
| TTM Free Cash FlowTrailing 4 quarters | $42.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $16.4M | $-10.3M | ||
| Q3 25 | $10.5M | $-6.6M | ||
| Q2 25 | $8.0M | $-15.0M | ||
| Q1 25 | $12.8M | $-17.0M | ||
| Q4 24 | $18.2M | $-32.4M | ||
| Q3 24 | $11.8M | $-18.8M | ||
| Q2 24 | $23.1M | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | $15.7M | $-12.2M | ||
| Q3 25 | $9.0M | $-9.5M | ||
| Q2 25 | $6.6M | $-17.8M | ||
| Q1 25 | $11.1M | $-18.8M | ||
| Q4 24 | $17.5M | $-33.6M | ||
| Q3 24 | $10.7M | $-19.0M | ||
| Q2 24 | $20.6M | $-16.8M |
| Q1 26 | — | — | ||
| Q4 25 | 15.7% | -15.9% | ||
| Q3 25 | 9.2% | -11.4% | ||
| Q2 25 | 6.8% | -22.5% | ||
| Q1 25 | 12.0% | -27.2% | ||
| Q4 24 | 17.6% | -49.2% | ||
| Q3 24 | 10.8% | -32.6% | ||
| Q2 24 | 20.0% | -31.4% |
| Q1 26 | — | — | ||
| Q4 25 | 0.7% | 2.4% | ||
| Q3 25 | 1.4% | 3.4% | ||
| Q2 25 | 1.4% | 3.5% | ||
| Q1 25 | 1.8% | 2.7% | ||
| Q4 24 | 0.6% | 1.7% | ||
| Q3 24 | 1.1% | 0.4% | ||
| Q2 24 | 2.4% | 2.0% |
| Q1 26 | — | — | ||
| Q4 25 | 1.52× | — | ||
| Q3 25 | 0.80× | — | ||
| Q2 25 | 0.81× | — | ||
| Q1 25 | 1.41× | — | ||
| Q4 24 | 1.78× | — | ||
| Q3 24 | 1.15× | — | ||
| Q2 24 | 2.16× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EBF
Segment breakdown not available.
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
